Riskpilot← Back to searchSign inGet full accessDr Delic AB
ABActiveOrg 5594034646Storahultsgatan 9General medical practice activities · NACE 8621Est. 20221 employees
Revenue 2024
SEK 2,5M
+26% vs 2023
EBITDA margin
60.2%
+102% vs 2023
Equity ratio
76.6%
Financial strength
Net profit 2024
SEK 1,2M
+103% vs 2023
| Revenue | SEK 2,5M | +26% |
| EBITDA | SEK 1,5M | +102% |
| Net profit | SEK 1,2M | +103% |
| Total assets | SEK 1,9M | +115% |
| Equity | SEK 1,5M | +132% |
| Employees | 1 | — |
Legal name
Dr Delic AB
Org number
5594034646
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
28 oktober 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska utöva konsultverksamhet inom hälso- och sjukvård, läkaruthyrning, medicinsk rådgivning, utbildningar och uthyrning av annan sjukvårdspersonal samt därmed förenlig verksamhet. Företaget ska erbjuda läkarbemanning på sjukhus, vårdcentraler och andra vårdinrättningar, friskvård, pedagogiska och konsultativa åligganden samt därmed förenlig verksamhet. Bolaget ska bedriva verksamhet inom import, export och handel med sjukvårdsartiklar och medicinskt material. Bolaget ska också äga och förvalta fast och lös egendom och därmed förenlig verksamhet.
Address
Storahultsgatan 9
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 2 018 | 2 535 |
| Staff expenses | — | −964 |
| EBITDA | 755 | 1 527 |
| Depreciation & amort. | −0 | — |
| EBIT | 755 | 1 527 |
| Net financials | — | 5 |
| Profit before tax | 754 | 1 533 |
| Tax | −155 | −315 |
| Net profit | 599 | 1 218 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 882 | 1 893 |
| Equity | 624 | 1 450 |
| Long-term debt | 0 | — |
| Short-term debt | 258 | 443 |
| Total debt | 258 | 443 |
EBITDA margin
60.2%
This company
15.8%
Market median
+281% vs market
20232024
Equity ratio
76.6%
This company
38.2%
Market median
+101% vs market
20232024
Return on equity
84.0%
This company
18.4%
Market median
+357% vs market
20232024
Net profit margin
48.0%
This company
8.1%
Market median
+493% vs market
20232024
Asset turnover
1.34×
This company
1.12×
Market median
+20% vs market
20232024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20232024
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Delic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Edin Delic | Board of Directors | 0 companies |
| Erik Alexander Stötsberg | Deputy Board Member | 0 companies |
| Sanela Delic | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |